1. Home
  2. RVMD vs DRI Comparison

RVMD vs DRI Comparison

Compare RVMD & DRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Revolution Medicines Inc.

RVMD

Revolution Medicines Inc.

HOLD

Current Price

$190.67

Market Cap

30.1B

Sector

Health Care

ML Signal

HOLD

Logo Darden Restaurants Inc.

DRI

Darden Restaurants Inc.

HOLD

Current Price

$209.97

Market Cap

25.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
RVMD
DRI
Founded
2014
1968
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
30.1B
25.9B
IPO Year
2020
2000

Fundamental Metrics

Financial Performance
Metric
RVMD
DRI
Price
$190.67
$209.97
Analyst Decision
Strong Buy
Buy
Analyst Count
19
25
Target Price
$140.84
$226.50
AVG Volume (30 Days)
1.6M
715.7K
Earning Date
05-06-2026
03-19-2026
Dividend Yield
N/A
3.06%
EPS Growth
N/A
17.16
EPS
N/A
10.38
Revenue
N/A
$13,210,900,000.00
Revenue This Year
N/A
$10.58
Revenue Next Year
$533.02
$3.73
P/E Ratio
N/A
$19.92
Revenue Growth
N/A
9.39
52 Week Low
$42.18
$169.00
52 Week High
$224.31
$229.76

Technical Indicators

Market Signals
Indicator
RVMD
DRI
Relative Strength Index (RSI) 34.73 45.49
Support Level $177.04 $189.02
Resistance Level $194.19 $212.53
Average True Range (ATR) 7.15 4.78
MACD -2.74 -1.21
Stochastic Oscillator 6.27 17.89

Price Performance

Historical Comparison
RVMD
DRI

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.

About DRI Darden Restaurants Inc.

Darden Restaurants is the largest global full-service dining operator, with over $12 billion in system sales across 2,159 company-owned stores at the end of fiscal 2025, spanning the US and Canada. The firm operates 10 banners in four segments, including Olive Garden (43% of sales), LongHorn Steakhouse (25%), and fine dining (21%), which includes The Capital Grille, Ruth's Chris, and Eddie V's. The other 11% of sales comes from smaller concepts such as Yard House and Cheddar's. Darden primarily generates revenue through sales of food and beverage items at its company-owned restaurants. It also earns royalties on sales from 154 franchised locations in US and international markets, which sit within the other segment but are immaterial to consolidated results.

Share on Social Networks: